SPECIAL SECTION Biomarkers, Surrogate End Points, and the Acceleration of Drug Development for Cancer Prevention and Treatment: An Update Prologue
نویسندگان
چکیده
Gary J. Kelloff, Robert C. Bast, Jr., Donald S. Coffey, Anthony V. D’Amico, Robert S. Kerbel, John W. Park, Raymond W. Ruddon, Gordon J. S. Rustin, Richard L. Schilsky, Caroline C. Sigman, and George F. Vande Woude Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland; Department of Translational Research, University of Texas M. D. Anderson Cancer Center, Houston, Texas; Johns Hopkins Hospital, Baltimore, Maryland; Brigham and Women’s Hospital, Boston, Massachusetts; Toronto-Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada; University of California, San Francisco Cancer Center, San Francisco, California; Johnson & Johnson Corporation, New Brunswick, New Jersey; Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, Middlesex, United Kingdom; Biological Sciences Division, University of Chicago, Chicago, Illinois; CCS Associates, Mountain View, California; and Van Andel Research Institute, Grand Rapids, Michigan
منابع مشابه
Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: an update prologue.
Gary J. Kelloff, Robert C. Bast, Jr., Donald S. Coffey, Anthony V. D’Amico, Robert S. Kerbel, John W. Park, Raymond W. Ruddon, Gordon J. S. Rustin, Richard L. Schilsky, Caroline C. Sigman, and George F. Vande Woude Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland; Department of Translational Research, University of Texas M. D. Anderson Cancer Center, Hou...
متن کاملBacterial and tissue biomarkers of gastric cancer: new findings and future perspectives: review article
Gastric cancer (GC) is the second leading cause of cancer-related deaths worldwide. It has been proposed that the specific genotypes of Helicobacter pylori (H. pylori) are the causative agents in the development of gastroduodenal diseases, such as chronic atrophic gastritis, peptic ulcerations, and GC. However, disease progression to GC occurs in only a small proportion of infected patients. Re...
متن کاملPerspectives on surrogate end points in the development of drugs that reduce the risk of cancer.
This paper proposes a scientific basis and possible strategy for applying surrogate end points in chemopreventive drug development. The potential surrogate end points for cancer incidence described are both phenotypic (at the tissue, cellular, and molecular levels) and genotypic biomarkers. To establish chemopreventive efficacy in randomized, placebo-controlled clinical trials, it is expected t...
متن کاملDevelopment of Alcohol Treatment Services Models in Iran
The international data have indicated a growing trend of alcohol use worldwide during recent years. Although alcohol use is against cultural norms and religious law in Iran, anecdotal reports from substance abuse treatment providers show that there is demand for alcohol treatment in the country. A recent national report also documented alcohol use disorders in Iran. Development and implementati...
متن کاملRole of Molecular Biomarkers in Colorectal Cancer
Colorectal cancer (CRC) is amongst the most widespread cancers and is a most common cause of cancer associated mortality universally. Since previous decades, it has been cleared that CRC develops owing to the buildup of a series of genetic and epigenetic changes in the normal colonic epithelium. Regardless of the current development in surgery and therapies, overall survival of end stage CRC pa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2004